Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2018 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption.
Sobhani N, Neeli PK, D'Angelo A, Pittacolo M, Sirico M, Galli IC, Roviello G, Nesi G. Sobhani N, et al. Int J Mol Sci. 2021 May 24;22(11):5515. doi: 10.3390/ijms22115515. Int J Mol Sci. 2021. PMID: 34073713 Free PMC article. Review.
Anti-AR-V7 drugs have shown promise in recent clinical investigations on this subset of patients. This mini-review focuses on the relevance of AR-V7 in the clinical manifestations of castration-resistant prostate cancer (CRPC) and summarizes redemptive therapeutic s …
Anti-AR-V7 drugs have shown promise in recent clinical investigations on this subset of patients. This mini-review focuses on the rel …
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.
Sobhani N, Generali D, D'Angelo A, Aieta M, Roviello G. Sobhani N, et al. Invest New Drugs. 2018 Dec;36(6):1133-1137. doi: 10.1007/s10637-018-0653-2. Epub 2018 Aug 7. Invest New Drugs. 2018. PMID: 30083960 Review.
Unfortunately, even if several recently approved agents clinically improved the outcome of CRPC patients, none of these is curative especially for a splice version of the Androgen Receptor (AR) AR-V7, which is a variant of the receptor constitutively activated and d …
Unfortunately, even if several recently approved agents clinically improved the outcome of CRPC patients, none of these is curative especial …
Accommodative response under monocular and binocular conditions as a function of phoria in symptomatic and asymptomatic subjects.
Momeni-Moghaddam H, Goss DA, Sobhani M. Momeni-Moghaddam H, et al. Clin Exp Optom. 2014 Jan;97(1):36-42. doi: 10.1111/cxo.12074. Epub 2013 Jun 27. Clin Exp Optom. 2014. PMID: 23808381 Free article.
RESULTS: The accommodative lag in exophoric participants was lower under binocular conditions compared to monocular and in esophoric participants greater under binocular than under monocular conditions. The binocular accommodative response (AR) was greatest in participants …
RESULTS: The accommodative lag in exophoric participants was lower under binocular conditions compared to monocular and in esophoric partici …